Status:
COMPLETED
Down Syndrome and Continuous Positive Pressure Therapy
Lead Sponsor:
Institut Jerome Lejeune
Collaborating Sponsors:
Fondation Jérôme Lejeune
Conditions:
Down Syndrome
Obstructive Sleep Apnea Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the efficacy and tolerability of Continuous Positive Pressure for SAOS in Down Syndrome patients.
Eligibility Criteria
Inclusion
- Down Syndrome patients with an Obstructive Sleep Apnea Syndrome
- more than 18 years old
Exclusion
- predictable non-compliance of device
- non-compensated cardiopathy
- non-stable thyroxin treatment
- non-stable diabetes
Key Trial Info
Start Date :
November 16 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2012
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT00394290
Start Date
November 16 2006
End Date
December 31 2012
Last Update
March 26 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Jerome Lejeune
Paris, France, 75015